A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV
Clinical trial NCT03657810 · COMPLETED
Trial details
- NCT number
- NCT03657810
- Sponsor
- Charleston Laboratories, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2018-04-16
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.